Chapter 1 - Remdesivir

This is a listing of all citations in this chapter.

61

Umair Irfan, “The FDA approved remdesivir to treat Covid-19. Scientists are questioning the evidence.,” Vox (Oct. 24, 2020).

62

Jeremy Hsu, “Covid-19: What now for remdesivir?,” The BMJ 371 (Nov. 20, 2020): m4457.

63

Jon Cohen & Kai Kupferschmidt, “The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug,” Science (Oct. 28, 2020).

64

Umair Irfan, “The FDA approved remdesivir to treat Covid-19. Scientists are questioning the evidence,” Vox (Oct. 24, 2020).

65

Jon Cohen & Kai Kupferschmidt, “The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug,” Science (Oct. 28, 2020).

66

Science Media Centre, “expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19,” SMC (Apr. 11, 2020).

67

Science Media Centre, “expert reaction to a study about compassionate use of remdesivir for patients with severe COVID-19,” SMC (Apr. 11, 2020).

68

Steven Levy, “Bill Gates on Covid: Most US Tests Are ‘Completely Garbage,” Wired (Aug. 7, 2020).

69

Owen Dyer, “Covid-19: Remdesivir has little or no impact on survival, WHO trial shows,” The BMJ 371 (Published October 19, 2020):m4057.

70

FDA News Release, “FDA Approves First Treatment for COVID-19,” FDA (Oct.22, 2020).

71

Kari Oakes, “WHO backs off on remdesivir as FDA issues another EUA.’’ Regulatory Focus (Nov. 19, 2020).

72

Michael E. Ohl, et al., “Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19,” JAMA 4 no. 7 (2021):e2114741, doi:10.1001/jamanetworkopen.2021.14741.

73

PRAC reviews a signal with Veklury, PRAC (Oct. 2, 2020).

74

“EU medicines agency studies effect of COVID-19 drug on kidneys,” Euronews (Oct. 2, 2020).

75

CDC, “Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19): Clinical Management and Treatment,” Centers for Disease Control and Prevention (Feb. 16, 2120).

76

NIH, “COVID-19 Treatment Guidelines:Therapeutic Management of Hospitalized Adults With COVID-19,” NIH (Aug 25, 2021).

77

NIH, “COVID-19 Treatment Guidelines: General Management of Nonhospitalized Patients With Acute COVID-19,” NIH (Jul. 8, 2021).

78

Sanna Gevers, et al, “Remdesivir in COVID-19 Patients with Impaired Renal Function,” JASN 32 no. 2 (Feb. 2021):518-519.

79

Jonathan Grein, M.D., et al, “Compassionate Use of Remdesivir for Patients with Severe Covid-19,” N Engl J Med 382 (2020):2327-2336, doi: 10.1056/NEJMoa2007016.

79.1

Statista, “Coronavirus (COVID-19) deaths worldwide per one million population as of December 16, 2020, by country,” Statista (Dec. 16, 2020). *Under “Confirmed Deaths (absolute)” sort by greatest to least.

80

Tavares, “Remdesivir is approved for testing on coronavirus patients in Brazil and Europe,” Tavares.

81

Lisandra Paraguassu, Ricardo Brito, “After record COVID-19 deaths, Bolsonaro tells Brazilians to stop ‘whining’,” Reuters (Mar. 5, 2021).

82

“Kidney problems more prevalent in NYC COVID-19 patients,” Columbia (Jun. 8, 2020).